Early prostate cancer: clinical decision-making

Area of Science:

• Oncology
• Urology
• Medical treatment

Background:

• Prostate cancer is a prevalent malignancy globally, often requiring intervention.
• Early-stage prostate cancer management includes observation for select patients (elderly, comorbidities).
• Established curative options include radical prostatectomy and various radiotherapy techniques.

Purpose of the Study:

• To review major treatment options for early-stage prostate cancer.
• To discuss the advantages and disadvantages of each treatment modality.
• To provide a general management approach for clinicians.

Main Methods:

• Literature review of prostate cancer treatment modalities.
• Comparative analysis of local treatments (surgery, radiotherapy) and systemic therapies.
• Discussion of patient and disease factors influencing treatment selection.

Main Results:

• Local treatments (surgery, radiotherapy) offer comparable cure rates but differ in side-effect profiles.
• Adjuvant systemic treatments (hormones, chemotherapy) may gain importance in early-stage disease.
• Treatment selection is complex, depending on individual patient and disease characteristics.

Conclusions:

• Choosing the best treatment for early-stage prostate cancer requires careful consideration of multiple factors.
• Understanding the nuances of different treatment options is crucial for effective patient management.
• This review aims to guide clinicians in decision-making for early-stage prostate cancer patients.